Effect of WNK1 pathway inhibitors on transgene-activated colorectal cancer (CRC) in zebrafish. (A–F) Tg (ifabp:RPIA; myl7:EGFP) adult fish were treated by oral gavage with DMSO (n = 15), WNK463 (n = 15) or Closantel (n = 15) and compared with wildtype fish treated with DMSO (n = 14). QPCR analysis was performed for zebrafish transgene ribose 5-phosphate isomerase A (RPIA), CRC promoting gene cyclin D1 (ccnd1), zebrafish WNK1 orthologue (wnk1a and wnk1b), VEGF receptor-2 (flk1/vegfr2), and angiogenesis/metastasis marker gene matrix metallopeptidase 9 (mmp9). The statistical significance was analyzed by unpaired Student’s t-test. ns: non-significant, p > 0.05; *: 0.01 < p ≤ 0.05; **: 0.001 < p ≤ 0.01; ***: 0.0001 < p ≤ 0.001; ****: p ≤ 0.0001. (G) Representative H&E-stained sections of intestinal tract of RPIA transgenic fish treated with or without inhibitors. Scale bar = 20 μm. (H) Distribution of histopathological findings from tissue sections as shown in panel G. The statistical significance was analyzed by Chi-square test. ****: p ≤ 0.0001.
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and
ZFIN has permission only to display this image to its users.
Additional permissions should be obtained from the applicable author or publisher of the image.
Full text @ Cancers
Your Input Welcome
Thank you for submitting comments. Your input has been emailed to ZFIN curators who may contact you if
additional information is required.
Oops. Something went wrong. Please try again later.